Form 4: BlackRock Health Sciences Trust Portfolio Manager Reports Transactions in Company Stock and Phantom Shares

Sentiment:

SEC Form 4 Filing


Kyle McClements, a Portfolio Manager at BlackRock Health Sciences Trust, reports transactions involving common stock and phantom shares, including acquisitions, disposals, and vesting of phantom shares.

Summary

  • On January 31, 2025, Kyle McClements, a Portfolio Manager at BlackRock Health Sciences Trust, engaged in transactions involving the company's common stock and phantom shares.
  • McClements acquired 641.4377 shares of common stock and disposed of 641.4377 shares at a price of $40.92.
  • He also acquired 786.2903 phantom shares, which are the economic equivalent of common stock and payable in cash upon vesting.
  • Additionally, phantom shares granted in previous years (2022, 2023, and 2024) vested on January 31, 2025, resulting in the payout of cash for 215.6367, 141.2239, and 284.577 shares respectively.
  • Following these transactions, McClements directly owns 593 shares of common stock and various amounts of phantom shares from different grant dates.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports transactions without expressing any positive or negative outlook.

Industry Context

This filing is a routine disclosure of transactions by a company insider, which is a common occurrence in the financial industry. It provides transparency into the trading activities of key personnel and their alignment with the company's performance.

Stakeholder Impact

  • The transactions may provide stakeholders with insights into the portfolio manager's perspective on the company's stock.

Key Dates

DateDescription
01/31/2022Previously reported grant date of phantom shares vesting in equal installments over three years.
02/03/2022Date of Form 4 filing reporting phantom share grant on 01/31/2022.
01/31/2023Previously reported grant date of phantom shares vesting in equal installments over three years.
02/02/2023Date of Form 4 filing reporting phantom share grant on 01/31/2023.
01/31/2024Previously reported grant date of phantom shares vesting in equal installments over three years.
02/02/2024Date of Form 4 filing reporting phantom share grant on 01/31/2024.
01/31/2025Date of reported transactions: acquisition and disposal of common stock, acquisition of phantom shares, and vesting of previously granted phantom shares.
02/04/2025Date of Form 4 filing reporting the transactions on 01/31/2025.

Keywords

Form 4, BlackRock Health Sciences Trust, Kyle McClements, Portfolio Manager, Common Stock, Phantom Shares, Beneficial Ownership, Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.